Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical ...

The prospective, epidemiologic School Inner-City Asthma Study (SICAS) evaluated potential biomarkers of inflammation associated with radon exposure among children aged 4 to 13 years with persistent ...

Speaking at a recent Technology Networks’ symposium, Dr. Jason Reeves explained how AI is changing the development of ...

Q4 2024 Earnings Call Transcript March 17, 2025 Quanterix Corporation misses on earnings expectations. Reported EPS is $-0.3 ...

Q4 2024 Earnings Call Transcript March 20, 2025 Cibus, Inc. misses on earnings expectations. Reported EPS is $-0.87 EPS, ...

Founder, Chief Operating Officer, Director, Interim Chief Executive Officer; Cibus Inc Greg Gocal; Co-Founder, Executive Vice President, Chief Scientific Officer; Cibus Inc Laurence Alexander; Analyst ...

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, in partnership with Rarity Bioscience ...

The core technologies encompass the established areas of immunoassays, clinical chemistry and MDx, but two key technology drivers, both with a strong PoC focus, are microarrays and multiplex testing.